David Gifford Sells 1,779 Shares of National HealthCare (NYSEAMERICAN:NHC) Stock

National HealthCare Corporation (NYSEAMERICAN:NHC) Director David Gifford sold 1,779 shares of the company’s stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $225.42, for a total value of $401,022.18. Following the completion of the sale, the director owned 1,030 shares in the company, valued at $232,182.60. The trade was a 63.33% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

National HealthCare Stock Up 0.2%

NHC stock opened at $222.70 on Friday. The business has a 50 day moving average of $219.36 and a 200 day moving average of $189.89. The firm has a market cap of $3.49 billion, a PE ratio of 25.05 and a beta of 0.61. National HealthCare Corporation has a twelve month low of $111.24 and a twelve month high of $239.29.

National HealthCare (NYSEAMERICAN:NHC) last released its earnings results on Thursday, August 6th. The company reported $1.74 EPS for the quarter. National HealthCare had a return on equity of 10.03% and a net margin of 9.00%.The business had revenue of $408.03 million for the quarter.

National HealthCare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a $0.67 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $2.68 dividend on an annualized basis and a yield of 1.2%. National HealthCare’s payout ratio is presently 61.89%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on NHC. The Goldman Sachs Group upgraded shares of National HealthCare to a “strong-buy” rating in a research note on Monday, May 18th. BMO Capital Markets raised shares of National HealthCare to a “hold” rating in a research report on Monday, May 18th. Robert W. Baird raised National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. Finally, Royal Bank Of Canada upgraded National HealthCare to a “hold” rating in a research note on Monday, May 18th. Two investment analysts have rated the stock with a Strong Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy”.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Allworth Financial LP bought a new stake in National HealthCare in the 2nd quarter worth approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in shares of National HealthCare in the 2nd quarter worth $37,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of National HealthCare in the third quarter worth $25,000. Public Employees Retirement System of Ohio purchased a new stake in National HealthCare during the second quarter valued at $48,000. Finally, Quarry LP lifted its holdings in National HealthCare by 171.9% in the third quarter. Quarry LP now owns 261 shares of the company’s stock valued at $32,000 after acquiring an additional 165 shares during the period. Institutional investors own 56.44% of the company’s stock.

About National HealthCare

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.